Wintzell, Viktor

Glucagon‐like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study

Pasternak, B., Wintzell, V., Hviid, A., Eliasson, B., Gudbjörnsdottir, S., Jonasson, C., Hveem, K., Svanström, H., Melbye, M., & Ueda, P. (2024) · BMJ

Diabetes Treatment and ManagementThyroid Cancer Diagnosis and Treatment

Cited by 125

GLP-1 Receptor Agonist Use and Risk of Suicide Death

Ueda, P., Söderling, J., Wintzell, V., Svanström, H., Pazzagli, L., Eliasson, B., Melbye, M., Hviid, A., & Pasternak, B. (2024) · JAMA Internal Medicine

Diabetes Treatment and ManagementSuicide and Self-Harm Studies

Cited by 103

Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study

Engström, A., Wintzell, V., Melbye, M., Svanström, H., Eliasson, B., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Hviid, A., Ueda, P., et al. (2024) · Hepatology

Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment

Cited by 54

Use of DPP4 Inhibitors and GLP-1 Receptor Agonists and Risk of Intestinal Obstruction: Scandinavian Cohort Study

Ueda, P., Wintzell, V., Melbye, M., Eliasson, B., Söderling, J., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Svanström, H., Hviid, A., et al. (2024) · Clinical Gastroenterology and Hepatology

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 34

Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study

Ueda, P., Wintzell, V., Melbye, M., Eliasson, B., Svensson, A.-M., Franzén, S., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Svanström, H., et al. (2021) · Diabetologia

Cholangiocarcinoma and Gallbladder Cancer StudiesDiabetes Treatment and Management

Cited by 31